{{Rsnum
|rsid=9652472
|Gene=LIPC
|Chromosome=15
|position=58526584
|Orientation=plus
|GMAF=0.3012
|Gene_s=LIPC
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 93.8 | 6.2 | 0.0
| HCB | 46.7 | 37.8 | 15.6
| JPT | 47.7 | 38.6 | 13.6
| YRI | 10.0 | 48.3 | 41.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 46.7 | 37.8 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23536766
|Title=Pharmacometabolomics reveals racial differences in response to atenolol treatment
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}